Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model.
Daniel J G ThirionValérian PascheElias MatoukAmélie MarsotPublished in: Pediatric pulmonology (2020)
In conclusion, we developed the first nomogram to optimize initial amikacin dosing regimens in patients with CF based on this external evaluation of a recently published amikacin population PK model.